Duplications of the Functional CYP21A2 Gene Are Primarily Restricted to Q318X Alleles: Evidence for a Founder Effect
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
CONTEXT: Rare haplotypes with Q318X mutations and duplicated CYP21A2 genes have been reported to occur in different populations to a varying extent. Discrimination between a normal (Q318X mutation on one of the duplicated CYP21A2 genes) and a congenital adrenal hyperplasia (CAH, Q318X mutation without duplicated functional gene) allele is of importance, particularly for prenatal diagnosis and the respective genetic counseling. Although methods to differentiate between such alleles have been published only recently, it remains unclear with which frequency Q318X mutations are associated with duplicated CYP21A2 genes and whether these haplotypes have a common ancestry. SUBJECTS AND METHODS: Human leukocyte antigen (HLA) typing has been performed in 38 unrelated individuals and in 11 family members detected to carry a Q318X mutation in the course of CYP21 genotyping using sequence, multiplex ligation-dependent probe amplification, and Southern blot analyses. RESULTS: The majority (n = 32, 84.2%) of the 38 unrelated individuals carrying the Q318X mutation had the trimodular RCCX haplotype, carrying the Q318X mutation on a duplicated CYP21A2 gene. Twenty-two individuals of these 32 (68.8%) were of the rare HLA-B*50-Cw*06 haplotype, suggesting a common ancestry of this haplotype. In five (13.2%) of the 38 subjects, the Q318X mutation was not associated with a duplicated CYP21A2 gene and thus represents a CAH allele. None of these five patients had the above mentioned HLA haplotype. CONCLUSION: The majority of individuals in whom Q318X mutations are detected carry a duplicated functional CYP21A2 gene and the rare HLA-B*50-Cw*06 haplotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although enzyme function in vitro appears to be similar (111), clinical observations suggest that patients carrying the P30L allele are somewhat more symptomatic, straddling the border between SV and NC forms of CAH (213,222).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [213]
Citations
Cites
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Molecular biology of steroid hormone synthesis
MILLER, W. L. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-3-295 · Cited by 1,397
Blanchong, C. A., Zhou, B., Rupert, K. L., Chung, E. K., Jones, K. N., Sotos, J. F., Zipf, W. B., Rennebohm, R. M., & Yu, C. Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.12.2183 · Cited by 187 · cited 2×
“three or four modules being rare cases (4, 5).”
BackgroundYang, Z., Mendoza, A. R., Welch, T. R., Zipf, W. B., & Yu, C. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12147 · Cited by 184
Wedell, A., & Luthman, H. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.5.499 · Cited by 160
Inborn errors of adrenal steroidogenesis
New, M. I. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.09.013 · Cited by 152
Baumgartner-Parzer, S. M., Nowotny, P., Heinze, G., Waldhäusl, W., & Vierhapper, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1728 · Cited by 97 · cited 3×
“Genomic DNA was extracted from peripheral blood leukocytes according to standard methods (12, 13).”
MethodResultSelf-citationParajes, S., Quinteiro, C., Domínguez, F., & Loidi, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002138 · Cited by 87 · cited 11×
“%) of clinically unaffected Spanish individuals to carry such duplicated CYP21A2 genes with a Q318X mutation, whereas this haplotype was at first (6, 7) regarded as a rare one.”
BackgroundMethodInfluentialKoppens, P. F. J., Hoogenboezem, T., & DEGENHART, H. J. (2002) · Human Genetics · doi:10.1007/s00439-002-0810-7 · Cited by 77
Research works printed but not linked: 1
- Tsuji, 1991, Proc 11th International Histocompatibility Workshop and Conference, Vol 1
Cited by
Cooper, D. N., Krawczak, M., Polychronakos, C., Tyler-Smith, C., & Kehrer-Sawatzki, H. (2013) · Human Genetics · doi:10.1007/s00439-013-1331-2 · Cited by 645
“…paternal (Gln318Term) and maternal (Arg356Term) nonsense mutations of the CYP21A2 gene but lacked the normal clinical sequelae of congenital adrenal hyperplasia; this was found to be due to a duplication of the CYP21A2 gene on the paternal allele (Kleinle et al. 2009; Lekarev et al. 2013).”
BackgroundCongenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
New, M. I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Chitayat, D., Sun, L., Zaidi, M., Wilson, R. C., & Yuen, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300057110 · Cited by 365
Finkielstain, G. P., Chen, W., Mehta, S. P., Fujimura, F. K., Hanna, R. M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0319 · Cited by 192
“Q318X, a classic mutation widely associated with duplicated CYP21A2 haplotypes (37), was found in four of six parents carrying a CYP21A2 duplication.”
BackgroundCongenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 161
Baumgartner-Parzer, S., Witsch-Baumgartner, M., & Hoeppner, W. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0653-5 · Cited by 110
Self-citationConcolino, P., & Costella, A. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0319-y · Cited by 96
Comprehensive analysis of congenital adrenal hyperplasia using long-read sequencing
Liu, Y., Chen, M., Liu, J., Mao, A., Teng, Y., Yan, H., Zhu, H., Li, Z., Liang, D., & Wu, L. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac046 · Cited by 80
Non-classic congenital adrenal hyperplasia
Witchel, S. F. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.010 · Cited by 52
Nonclassic congenital adrenal hyperplasia
Witchel, S. F. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283534db2 · Cited by 42
“In other words, one allele carries both a normal CYP21A2 gene and a CYP21A2 gene with Q318X mutation [55].”
BackgroundFetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Genes and Pseudogenes: Complexity of the RCCX Locus and Disease
Carrozza, C., Foca, L., De Paolis, E., & Concolino, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.709758 · Cited by 37
Molecular diagnosis of steroid 21-hydroxylase deficiency: A practical approach
Arriba, M., & Ezquieta, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.834549 · Cited by 30
Tsai, L., Cheng, C., Chuang, S.-H., & Lee, H.-H. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.02.016 · Cited by 30
“However, haplotypes of the RCCX module with more than one CYP21A2 gene in the trimodular form were observed [14–19].”
BackgroundMolecular analysis of the CYP21A2 gene in Chinese patients with steroid 21-hydroxylase deficiency
Ma, D., Chen, Y., Sun, Y., Yang, B. Y., Cheng, J., Huang, M., Zhang, J., Zhang, J., Hu, P., Lin, Y., et al. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.01.019 · Cited by 29
Prenatal treatment of congenital adrenal hyperplasia-not standard of care
Witchel, S. F., & Miller, W. L. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-012-9508-8 · Cited by 29
“Most individuals have both a CYP21A1P pseudogene and an adjacent CYP21A2 gene on each allele, but normal individuals can have anywhere from 0 to 4 copies of the CYP21A1P pseudogene or the CYP21A2 functional gene on a single allele (Parajes et al. 2008; Kleinle et al. 2009).”
BackgroundMilacic, I., Barac, M., Milenković, T., Ugrin, M., Klaassen, K., Skakić, A., Jesic, M., Joksić, I., Mitrović, K., Todorovic, S., et al. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0366-8 · Cited by 29
“It is known that chromosomes with duplicated CYP21A2 gene are not rare and were reported in many populations [36].”
BackgroundChallenges in the diagnosis and management of disorders of sex development
KUTNEY, K. A., Konczal, L. L., Kaminski, B. A., & Uli, N. K. (2016) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21147 · Cited by 31
“Another 20–30% of patients will have findings on deletion/duplication testing (Parajes et al., 2008; Kleinle et al., 2009).”
BackgroundKharrat, M., Riahi, A., Maazoul, F., Mʼrad, R., & Chaabouni, H. (2011) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e3181f24807 · Cited by 25
Su, L., Yin, X., Cheng, J., Cai, Y., Wu, D., Feng, Z., & Liu, L. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.07.039 · Cited by 25
Li, H., Zhu, X., Yang, Y., Wang, W., Mao, A., Li, J., Bao, S., & Li, J. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117419 · Cited by 23
Carvalho, B., Marques, C. J., Silva, R. S., Fontoura, M., Carvalho, D. M., & Carvalho, F. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1108-1419 · Cited by 27
“Both, functional CYP21A2 and inactive pseudogene CYP21A1P together with their neighbouring genes tenascin TNXA/B, complement C4A/B, and the serine/threonine nuclear protein kinase RP, plus small truncated sections of TNX and RP, form a genetic unit designated as RCCX module [21].”
BackgroundInfluentialCoeli, F. B., Soardi, F. C., Bernardi, R. D., de Araújo, M., Paulino, L. C., Lau, I. F., Petroli, R. J., de Lemos-Marini, S. H., Baptista, M. T., Guerra-Júnior, G., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-104 · Cited by 23
“Although Real-Time PCR and HLA-haplotypes would be alternative techniques to estimate, respectively, C4 and CYP21A2 copy number [35-37] and founder effect they were not available for this work.”
MethodLekarev, O., Tafuri, K., Lane, A. H., Zhu, G., Nakamoto, J. M., Buller-Burckle, A. M., Wilson, T. A., & New, M. I. (2013) · Journal of Perinatology · doi:10.1038/jp.2012.5 · Cited by 21
Genes, pseudogenes and like genes: The case of 21-hydroxylase in Italian population
Concolino, P., Mello, E., Minucci, A., Giardina, B., & Capoluongo, E. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.019 · Cited by 21
Jang, J., Jin, D., Kim, J., Tan, H.-K., Kim, J.-W., Lee, S., Ki, C., & Park, H. (2011) · PubMed · Cited by 21
Doleschall, M., Luczay, A., Klara, K., Hadzsiev, K., Erhardt, É., Szilágyi, Á., Doleschall, Z., Németh, K., Török, D., Prohászka, Z., et al. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.38 · Cited by 21
Chen, W., Xu, Z., Nishitani, M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2012) · Human Genetics · doi:10.1007/s00439-012-1217-8 · Cited by 18
“High frequency of CNV has been found at the CYP21A2 locus (Kleinle et al. 2009; Koppens et al. 2002; Parajes et al. 2008; Sinnott et al. 1991; Wedell et al. 1994).”
BackgroundCoeli‐Lacchini, F. B., Turatti, W., Elias, P. C. L., Elias, L. L. K., Martinelli, C. E., Moreira, A. C., Antonini, S. R. R., & de Castro, M. (2013) · Gene · doi:10.1016/j.gene.2013.03.082 · Cited by 18
Toraman, B., Ökten, A., Kalay, E., Karagüzel, G., Dinçer, T., Açıkgöz, E. G., & Karagüzel, A. (2013) · Gene · doi:10.1016/j.gene.2012.10.059 · Cited by 14
Analysis of CYP21A1P and the duplicated CYP21A2 genes
Tsai, L., & Lee, H.-H. (2012) · Gene · doi:10.1016/j.gene.2012.06.045 · Cited by 15
Dubey, S., Tardy, V., Chowdhury, M. R., Gupta, N., Jain, V., Deka, D., Sharma, P., Morel, Y., & Kabra, M. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_329_16 · Cited by 16
Concolino, P., & Falhammar, H. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf018 · Cited by 12
“4:p.(Gln319Ter) within exon 8 [50].”
Variants of the CYP21A2 and CYP21A1P genes in congenital adrenal hyperplasia
Lee, H.-H. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.12.030 · Cited by 12
“2 (n=38) [46]”
BackgroundLan, T., Jin, W., Chen, K., Zhang, J., Chen, X., & Yao, H. J. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1472516 · Cited by 13
Wang, Y., Zhu, G., Li, D., Pan, Y., Li, R., Zhou, T., Mao, A., Chen, L., Zhu, J., & Zhu, M. (2025) · Human Genomics · doi:10.1186/s40246-024-00696-4 · Cited by 13
Couple-Based Carrier Screening: How Gene and Variant Considerations Impact Outcomes
Lee, E., Orton, K., Kwan, E., Faga, C., Le, T., Shaheen, R., Nair, V., & Cliffe, S. T. (2025) · Genes · doi:10.3390/genes16060671 · Cited by 7
Fanis, P., Skordis, N., Toumba, M., Picolos, M. K., Tanteles, G. A., Neocleous, V., & Phylactou, L. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1156616 · Cited by 8
“Gln319Ter often to be associated with an RCCX trimodular and duplicated CYP21A2 haplotype (33, 35), the unavailability of parental samples for more explicit haplotype analyses would be more appropriate to hypothesize this as described previously (36) (37).”
BackgroundLiang, D., Zhu, M., Liang, Q., Qiang, R., Yu, L., Xu, S., Li, M., Song, J., Zhou, Y., He, X., et al. (2025) · Genome Medicine · doi:10.1186/s13073-025-01594-7 · Cited by 11
“The imbalance of duplications to deletions found in this study is consistent with previous studies [3, 36, 37].”
Nan, M. N., Roig, R., Martínez, S., Rives, J., Urgell, E., Espinós, J. J., Tirado-Capistros, M., Carreras, G., Aulinas, A., Webb, S. M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061183 · Cited by 7
“(Gln319*), which has been found to be associated with functional duplications of the CYP21A2 gene in around 84% of patients [36].”
BackgroundConcolino, P. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05379-6 · Cited by 6
Fylaktou, I., Mertzanian, A., Farakla, I., Gryparis, A., Vasilakis, I. A., Binou, M., Charmandari, E., Kanaka‐Gantenbein, C., & Sertedaki, A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46100635 · Cited by 6
Malíková, J., Votava, F., Vrzalová, Z., Lebl, J., & Cinek, O. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04358.x · Cited by 7
Lack of genotypephenotype correlation in congenital adrenal hyperplasia due to a CYP21A2-like gene
Leccese, A., Longo, V., Dimatteo, C., Girolamo, G. D., Trunzo, R., D’Andrea, G., Bafunno, V., Margaglione, M., & Santacroce, R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.07.009 · Cited by 5
“Q318Xmutationwas associated, inmost cases, with the allele carrying the duplicated gene [10].”
BackgroundResultTan, J., Jin, S., Huang, L., Shao, B., Wang, Y., Wang, Y., Zhang, J., Su, M., Tan, J., Cheng, Q., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38222 · Cited by 4
CYP21A2 genetics: When genotype does not fit phenotype
Sani, I., Rossodivita, A. N., Mariani, M., Costella, A., Molinario, R., Concolino, P., & Capoluongo, E. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.07.022 · Cited by 4
Randhawa, H., Knoll, M. M., McPhaul, M. J., Dileepan, K., McDonough, R., Turpin, A. L., & Jacobson, J. D. (2024) · Transgender Health · doi:10.1089/trgh.2023.0033 · Cited by 4
Consejo genético en la hiperplasia suprarrenal congénita por déficit de 21-hidroxilasa
Fernández, B. H., Martín, M. B. R., Arnao, M. D. R., & Zubicaray, B. E. (2011) · Anales de Pediatría · doi:10.1016/j.anpedi.2011.08.004 · Cited by 4
Xia, Y., Yu, F., Bai, Y., Jiang, L., Shi, P., Jiang, Z., & Kong, X. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03414-4 · Cited by 2
Unexplained infertility: increased risk for 21-hydroxylase-deficiency in parents and offspring?
Baumgartner-Parzer, S. M., Vytiska-Binsdorfer, E., Kleinle, S., Heinze, G., & Vierhapper, H. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.09.014 · Cited by 2
“Since the patient carried a severe mutation (p.Gly110fs), CYP21A2-genotyping was also performed in her husband and did not reveal any aberrations.”
BackgroundInfluentialSelf-citationMolecular Genetics of 21‐Hydroxylase Deficiency
Parajes, S., & Krone, N. P. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0023845 · Cited by 2
Monlong, J., Chen, X., Barseghyan, H., Rowell, W. J., Negi, S., Nokoff, N., Mohnach, L. H., Hirsch, J. A., Finlayson, C. A., Keegan, C. E., et al. (2025) · medRxiv · doi:10.1101/2025.02.07.25321404 · Cited by 3
Pignatelli, D., & Pereira, S. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_2 · Cited by 1
Schernthaner-Reiter, M. H., Riedl, S., Obermayer-Pietsch, B. M., Krebs, M., Vila, G., Kleinle, S., Esterbauer, H., & Baumgartner-Parzer, S. M. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf217 · Cited by 3
Self-citationDubey, S., Saxena, R., Kohli, S., Jaswal, H., Rawat, A., Singh, K., Bijarnia‐Mahay, S., Arora, V., Maitra, A., Saravana, C., et al. (2026) · The Indian Journal of Pediatrics · doi:10.1007/s12098-025-05918-8 · Cited by 2
Genetics of Congenital Adrenal Hyperplasia
Krone, N. P. (2022) · doi:10.1093/med/9780198870197.003.0104 · Cited by 1
Figueras, L. M., Muñoz‐Pacheco, R., González, D. G., Arriba, M., & Zubicaray, B. E. (2023) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2023-0071 · Cited by 4
Molecular Genetics of Congenital Adrenal Hyperplasia
Parajes, S., & Krone, N. P. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0023590 · Cited by 1
Navigating the Complex Landscape of CYP21A2 Variants
Dubey, S., & Gupta, N. (2023) · The Indian Journal of Pediatrics · doi:10.1007/s12098-023-04951-9 · Cited by 1
Concolino, P., Mello, E., Rossodivita, A. N., Giardina, B., & Capoluongo, E. (2013) · Gene · doi:10.1016/j.gene.2013.09.035
Baumgartner-Parzer, S. M., & Schernthaner-Reiter, M. H. (2021) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-021-00150-z
“Exon/ Intron-Grenzbereiche auch eine Methodik zurDetektionvongroßenDeletionen und Duplikationen [21] des CYP21A2Gens.”
BackgroundInfluentialSelf-citationFigueras, L. M., Muñoz‐Pacheco, R., González, D. G., Arriba, M., & Zubicaray, B. E. (2023) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2023-0050 · Cited by 2
CYP21A2 Gene Analysis in Southern Iranian CAH Patients and a Brief Review of the Mutation Spectrum
Zangene, D., Moravej, H., Ilkhanipoor, H., Amirhakimi, A., Afshar, Z., & Entezam, M. (2024) · Avicenna Journal of Medical Biotechnology · doi:10.18502/ajmb.v16i2.14864
“Moreover, it is suggested as a founder mutation in some populations 35,37 .”
BackgroundChen, X., Zhao, J., Li, D., Na, X., Yi, D., Yan, M., Yin, Y., & Wang, X. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70029
“…and unequal crossing over during meiosis, cause the CYP21A1P/CYP21A2 chimeras with a 30 kb deletion including the CYP21A2 gene and the 3′ portion of the TNXB gene and duplicated CYP21A2 , which might complicate the determination of carrier status (Ezquieta et al. 2006; Kleinle et al. 2009).”
Li, X., Zhang, C., Liu, D., Shang, H., Wang, K., Lin, X., & Zheng, J. (2025) · Journal of Pain Research · doi:10.2147/jpr.s554433
“CYP21A2 is a steroid synthase involved in adrenal hormone metabolism, and its dysfunction may cause hormonal imbalance, 55–58 which might exacerbate neuroinflammation or oxidative stress associated with AD, and could also potentially worsen insulin resistance or vascular damage related to DN…”
Fylaktou, I., Tsinopoulou, V. R., Sertedaki, A., Kanaka‐Gantenbein, C., & Galli‐Τsinopoulou, A. (2025) · Case Reports in Endocrinology · doi:10.1155/crie/1599576
Szklarz, M., Wołos-Kłosowicz, K., Szulc, J., Górny, J. M., & Matuszewski, W. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00364-8
“A more sensitive method is MPLA (multiplex ligation-dependent probe amplification), which requires less DNA to detect gene deletions, rearrangements and fusions [32].”
Metadata
- Authors
- Kleinle, S., Lang, R., Fischer, G. F., Vierhapper, H., Waldhauser, F., Födinger, M., & Baumgartner-Parzer, S. M.
- Affiliations
- Medical University of Vienna (AT)
- Kaiser Franz Josef Spital (M.F.), A-1100 Vienna, Austria
- Corresponding author
- Baumgartner-Parzer, S. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-10-01
- Volume
- 94
- Issue
- 10
- Pages
- 3954-3958
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2123336423
- Cited by
- 67
- References
- 16
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 6 · 2023: 6 · 2022: 3 · 2021: 5 · 2020: 3 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 3 · 2014: 4 · 2013: 7 · 2012: 8
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- congenital adrenal hyperplasia, founder effect, HLA haplotypes, prenatal diagnosis, genetic counseling
- MeSH terms
- Adrenal Hyperplasia, Congenital, Adult, Alleles, Female, Gene Amplification, Genotype, Glutamine, Haplotypes, Heterozygote, Humans, Male, Middle Aged, Mutation, Steroid 21-Hydroxylase, Blotting, Southern, HLA-B Antigens, Founder Effect, Gene Duplication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.